Literature DB >> 22009142

Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger?

Anne P L Jensen-Urstad1, Clay F Semenkovich.   

Abstract

Fatty acid synthase (FAS) catalyzes the de novo synthesis of fatty acids. In the liver, FAS has long been categorized as a housekeeping protein, producing fat for storage of energy when nutrients are present in excess. Most previous studies of FAS regulation have focused on the control of gene expression. However, recent findings suggest that hepatic FAS may also be involved in signaling processes that include activation of peroxisome proliferator-activated receptor α (PPARα). Moreover, reports of rapid alterations in FAS activity as well as findings of post-translational modifications of the FAS protein support the notion that dynamic events in addition to transcription impact FAS regulation. These results indicate that FAS enzyme activity can impact liver physiology through signaling as well as energy storage and that its regulation may be complex. This article is part of a Special Issue entitled Triglyceride Metabolism and Disease.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009142      PMCID: PMC3288544          DOI: 10.1016/j.bbalip.2011.09.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  82 in total

Review 1.  Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

Authors:  Scott M Grundy; H Bryan Brewer; James I Cleeman; Sidney C Smith; Claude Lenfant
Journal:  Circulation       Date:  2004-01-27       Impact factor: 29.690

2.  Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin.

Authors:  Coen H Wiegman; Robert H J Bandsma; Margriet Ouwens; Fjodor H van der Sluijs; Rick Havinga; Theo Boer; Dirk-Jan Reijngoud; Johannes A Romijn; Folkert Kuipers
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

3.  Suppression of fatty acid synthase promoter by polyunsaturated fatty acids.

Authors:  Yang Soo Moon; Maria-Jesus Latasa; Michael J Griffin; Hei Sook Sul
Journal:  J Lipid Res       Date:  2002-05       Impact factor: 5.922

4.  Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility.

Authors:  Hong Lan; Mary E Rabaglia; Jonathan P Stoehr; Samuel T Nadler; Kathryn L Schueler; Fei Zou; Brian S Yandell; Alan D Attie
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

5.  Control of the synthesis of fatty-acid synthetase in rat liver by insulin, glucagon, and adenosine 3':5' cyclic monophosphate.

Authors:  M R Lakshmanan; C M Nepokroeff; J W Porter
Journal:  Proc Natl Acad Sci U S A       Date:  1972-12       Impact factor: 11.205

6.  Fatty acid synthesis is essential in embryonic development: fatty acid synthase null mutants and most of the heterozygotes die in utero.

Authors:  Subrahmanyam S Chirala; Hua Chang; Martin Matzuk; Lutfi Abu-Elheiga; Jianqiang Mao; Kathleen Mahon; Milton Finegold; Salih J Wakil
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-08       Impact factor: 11.205

7.  Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver.

Authors:  Guoxun Chen; Guosheng Liang; Jiafu Ou; Joseph L Goldstein; Michael S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-20       Impact factor: 11.205

8.  Suppression of hepatic fatty acid synthase by feeding alpha-linolenic acid rich perilla oil lowers plasma triacylglycerol level in rats.

Authors:  Hye-Kyeong Kim; Sungwon Choi; Haymie Choi
Journal:  J Nutr Biochem       Date:  2004-08       Impact factor: 6.048

9.  Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms.

Authors:  Makoto Miyazaki; Agnieszka Dobrzyn; Weng Chi Man; Kiki Chu; Harini Sampath; Hyoun-Ju Kim; James M Ntambi
Journal:  J Biol Chem       Date:  2004-04-05       Impact factor: 5.157

10.  Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.

Authors:  Renaud Dentin; Jean-Paul Pégorier; Fadila Benhamed; Fabienne Foufelle; Pascal Ferré; Véronique Fauveau; Mark A Magnuson; Jean Girard; Catherine Postic
Journal:  J Biol Chem       Date:  2004-02-25       Impact factor: 5.157

View more
  84 in total

1.  Avasimibe encapsulated in human serum albumin blocks cholesterol esterification for selective cancer treatment.

Authors:  Steve Seung-Young Lee; Junjie Li; Jien Nee Tai; Timothy L Ratliff; Kinam Park; Ji-Xin Cheng
Journal:  ACS Nano       Date:  2015-02-16       Impact factor: 15.881

2.  Dietary silymarin supplementation promotes growth performance and improves lipid metabolism and health status in grass carp (Ctenopharyngodon idellus) fed diets with elevated lipid levels.

Authors:  Peizhen Xiao; Hong Ji; Yuantu Ye; Baotong Zhang; Yongsheng Chen; Jingjing Tian; Pin Liu; Liqiao Chen; Zhenyu Du
Journal:  Fish Physiol Biochem       Date:  2016-09-08       Impact factor: 2.794

3.  Epidermal growth factor receptor plays a role in the regulation of liver and plasma lipid levels in adult male mice.

Authors:  Lawrence A Scheving; Xiuqi Zhang; Oscar A Garcia; Rebecca F Wang; Mary C Stevenson; David W Threadgill; William E Russell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-09       Impact factor: 4.052

4.  Fatty acid synthesis tips the TH17-Treg cell balance.

Authors:  David O'Sullivan; Erika L Pearce
Journal:  Nat Med       Date:  2014-11       Impact factor: 53.440

5.  Peroxisomal lipid synthesis regulates inflammation by sustaining neutrophil membrane phospholipid composition and viability.

Authors:  Irfan J Lodhi; Xiaochao Wei; Li Yin; Chu Feng; Sangeeta Adak; Grazia Abou-Ezzi; Fong-Fu Hsu; Daniel C Link; Clay F Semenkovich
Journal:  Cell Metab       Date:  2015-01-06       Impact factor: 27.287

6.  Cranberry (Vaccinium macrocarpon) extract treatment improves triglyceridemia, liver cholesterol, liver steatosis, oxidative damage and corticosteronemia in rats rendered obese by high fat diet.

Authors:  Thamara C Peixoto; Egberto G Moura; Elaine de Oliveira; Patrícia N Soares; Deysla S Guarda; Dayse N Bernardino; Xu Xue Ai; Vanessa da S T Rodrigues; Gabriela Rodrigues de Souza; Antonio Jorge Ribeiro da Silva; Mariana S Figueiredo; Alex C Manhães; Patrícia C Lisboa
Journal:  Eur J Nutr       Date:  2017-05-13       Impact factor: 5.614

7.  TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation.

Authors:  Bart Everts; Eyal Amiel; Stanley Ching-Cheng Huang; Amber M Smith; Chih-Hao Chang; Wing Y Lam; Veronika Redmann; Tori C Freitas; Julianna Blagih; Gerritje J W van der Windt; Maxim N Artyomov; Russell G Jones; Erika L Pearce; Edward J Pearce
Journal:  Nat Immunol       Date:  2014-02-23       Impact factor: 25.606

8.  FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice.

Authors:  Timothy D Rohrbach; Amon Asgharpour; Melissa A Maczis; David Montefusco; L Ashley Cowart; Pierre Bedossa; Arun J Sanyal; Sarah Spiegel
Journal:  J Lipid Res       Date:  2019-05-20       Impact factor: 5.922

9.  Diet regulates liver autophagy differentially in murine acute Trypanosoma cruzi infection.

Authors:  Kezia Lizardo; Vanessa Almonte; Calvin Law; Janeesh Plakkal Aiyyappan; Min-Hui Cui; Jyothi F Nagajyothi
Journal:  Parasitol Res       Date:  2016-12-16       Impact factor: 2.289

10.  Nutrient-dependent phosphorylation channels lipid synthesis to regulate PPARα.

Authors:  Anne P L Jensen-Urstad; Haowei Song; Irfan J Lodhi; Katsuhiko Funai; Li Yin; Trey Coleman; Clay F Semenkovich
Journal:  J Lipid Res       Date:  2013-04-13       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.